SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027390
Filing Date
2016-11-03
Accepted
2016-11-03 16:31:17
Documents
50
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vtvt-10q_20160930.htm 10-Q 1149444
2 EX-31.1 vtvt-ex311_8.htm EX-31.1 16203
3 EX-31.2 vtvt-ex312_6.htm EX-31.2 16095
4 EX-32.1 vtvt-ex321_9.htm EX-32.1 7265
5 EX-32.2 vtvt-ex322_7.htm EX-32.2 7220
6 GRAPHIC g2016110219252878310537.jpg GRAPHIC 25310
  Complete submission text file 0001564590-16-027390.txt   3757595

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vtvt-20160930.xml EX-101.INS 516516
8 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20160930.xsd EX-101.SCH 39384
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20160930_cal.xml EX-101.CAL 31838
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20160930_def.xml EX-101.DEF 166124
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20160930_lab.xml EX-101.LAB 295692
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20160930_pre.xml EX-101.PRE 222992
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 161972100
SIC: 2834 Pharmaceutical Preparations